EUVIMEDEUVIMED entdecken
Open Access

Concomitant Antiseizure Medications' Influence on Valproic Acid and Levetiracetam Pharmacokinetics in Pediatric Patients

Zühal Kaltuş iD, Sevgi Yimenicioğlu iD, Ezgi Eroğlu iD, Cefa Nil Arslan Karademir iD

Pediatrics International · 2026-01 · 68 (1)

DOI: 10.1111/ped.70510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 13.08.2026. Verfasst von Zühal Kaltuş und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Pharmacology of Eskisehir City Hospital, Eskisehir, Turkey. Hauptthemen laut MEDLINE: Levetiracetam, Valproic Acid, Anticonvulsants, Epilepsy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Valproic acid (VPA) and levetiracetam (LEV) are among the most widely used anti‐seizure medications (ASMs) in pediatric epilepsy. Although they share the common goal of seizure control, these drugs exhibit distinct pharmacokinetic characteristics, which can influence therapeutic drug monitoring (TDM), dosing strategies, and treatment response.

Objective

This study aims to compare the intra‐drug pharmacokinetic profiles of VPA and LEV in pediatric patients, focusing on dose‐normalized concentration (C 0 /mg/kg). The study also investigates the impact of concomitant enzyme‐inducing or enzyme‐inhibiting drugs on these parameters.

Methods

The analysis included 1141 serum samples from 817 patients (447 VPA; 370 LEV). Pediatric patients receiving monotherapy or combination therapy with one of two anti‐seizure medications were retrospectively analyzed. Pharmacokinetic indices were compared using descriptive and nonparametric methods. Subgroup analysis was performed according to concomitant drugs affecting liver metabolism.

Results

A moderately positive correlation was observed between daily LEV dose and serum concentration ( r = 0.47, p < 0.0001), while VPA showed a weaker but significant dose‐concentration relationship ( r = 0.31, p < 0.001; R 2 = 0.096). Dose‐normalized minimum concentrations (C 0 /mg/kg) differed significantly between treatment groups for both drugs. In the VPA group, concomitant use of enzyme inducers was associated with significantly lower C 0 /mg/kg values compared with both monotherapy and neutral co‐medication groups ( p < 0.001). Similarly, the LEV+ inducer group showed significantly different C 0 /mg/kg values than levetiracetam monotherapy ( p = 0.005). Neutral concomitant drugs did not significantly affect C 0 /mg/kg for either drug.

Conclusion

Concomitant enzyme‐inducing ASM significantly reduced dose‐normalized trough concentrations of VPA and LEV, while neutral co‐medications had no effect, highlighting the importance of TDM in pediatric combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevetiracetamValproic AcidAnticonvulsantsEpilepsyHumansChildRetrospective StudiesFemaleMaleChild, PreschoolDrug MonitoringDrug Therapy, CombinationAdolescentDrug InteractionsDose-Response Relationship, DrugInfant

Stichwörter der Autor:innen

levetiracetampediatric epilepsypharmacokineticstherapeutic drug monitoringvalproic acid

Substanzen

LevetiracetamValproic AcidAnticonvulsants

Autor:innen und Institutionen

  • Medical Pharmacology of Eskisehir City Hospital, Eskisehir, Turkey.
  • Pediatric Neurology Department, Health Practice and Research Centers, Eskişehir City Hospital, Health Sciences University, Eskisehir, Turkey.
  • Clinical Research Department, Turkish Medicines and Medical Devices Agency, Ankara, Turkey.
  • Department of Pediatric Neurology, Eskişehir City Hospital, Eskisehir, Turkey.

ORCID-Profile: Zühal Kaltuş, Sevgi Yimenicioğlu, Ezgi Eroğlu, Cefa Nil Arslan Karademir

Zitieren

APA

Kaltuş, Z., Yimenicioğlu, S., Eroğlu, E., & Karademir, C. N. A. (2026). Concomitant Antiseizure Medications' Influence on Valproic Acid and Levetiracetam Pharmacokinetics in Pediatric Patients. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70510

Vancouver

Kaltuş Z, Yimenicioğlu S, Eroğlu E, Karademir CNA. Concomitant Antiseizure Medications' Influence on Valproic Acid and Levetiracetam Pharmacokinetics in Pediatric Patients. Pediatrics International. 2026;68(1). doi:10.1111/ped.70510

BibTeX
@article{Kaltu2026,
  author = {Kaltuş, Zühal and Yimenicioğlu, Sevgi and Eroğlu, Ezgi and Karademir, Cefa Nil Arslan},
  title = {Concomitant Antiseizure Medications' Influence on Valproic Acid and Levetiracetam Pharmacokinetics in Pediatric Patients},
  journal = {Pediatrics International},
  year = {2026},
  volume = {68},
  number = {1},
  doi = {10.1111/ped.70510}
}
Kostenlos starten →